These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 2340510)
1. Changes in glutathione content and resistance to anticancer agents in human stomach cancer cells induced by treatments with melphalan in vitro. Barranco SC; Townsend CM; Weintraub B; Beasley EG; MacLean KK; Shaeffer J; Liu NH; Schellenberg K Cancer Res; 1990 Jun; 50(12):3614-8. PubMed ID: 2340510 [TBL] [Abstract][Full Text] [Related]
2. Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells. Lai SL; Hwang J; Perng RP; Whang-Peng J Oncol Res; 1995; 7(1):31-8. PubMed ID: 7549042 [TBL] [Abstract][Full Text] [Related]
3. Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion. Green JA; Vistica DT; Young RC; Hamilton TC; Rogan AM; Ozols RF Cancer Res; 1984 Nov; 44(11):5427-31. PubMed ID: 6488194 [TBL] [Abstract][Full Text] [Related]
4. Glutathione and related enzymes in rat brain tumor cell resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea and nitrogen mustard. Evans CG; Bodell WJ; Tokuda K; Doane-Setzer P; Smith MT Cancer Res; 1987 May; 47(10):2525-30. PubMed ID: 2882834 [TBL] [Abstract][Full Text] [Related]
6. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine. Kramer RA; Greene K; Ahmad S; Vistica DT Cancer Res; 1987 Mar; 47(6):1593-7. PubMed ID: 3815359 [TBL] [Abstract][Full Text] [Related]
7. Intercellular transfer of drug resistance. Frankfurt OS; Seckinger D; Sugarbaker EV Cancer Res; 1991 Feb; 51(4):1190-5. PubMed ID: 1997161 [TBL] [Abstract][Full Text] [Related]
8. Radiation resistance in a melphalan-resistant subline of a rat mammary carcinoma. Lehnert S; Vestergaard J; Batist G; Aloui-Jamali MA Radiat Res; 1994 Aug; 139(2):232-9. PubMed ID: 8052700 [TBL] [Abstract][Full Text] [Related]
9. Development and characterization of a melphalan-resistant human multiple myeloma cell line. Bellamy WT; Dalton WS; Gleason MC; Grogan TM; Trent JM Cancer Res; 1991 Feb; 51(3):995-1002. PubMed ID: 1988143 [TBL] [Abstract][Full Text] [Related]
10. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance. Xu BH; Gupta V; Singh SV Arch Biochem Biophys; 1994 Jan; 308(1):164-70. PubMed ID: 8311448 [TBL] [Abstract][Full Text] [Related]
11. Sensitivity of human melanoma cells to L-dopa and DL-buthionine (S,R)-sulfoximine. Kable EP; Favier D; Parsons PG Cancer Res; 1989 May; 49(9):2327-31. PubMed ID: 2706620 [TBL] [Abstract][Full Text] [Related]
12. Rapid development of drug resistance in human ovarian tumor xenografts after a single treatment with melphalan in Vivo. Caffrey PB; Zhang Y; Frenkel GD Anticancer Res; 1998; 18(4C):3021-5. PubMed ID: 9713503 [TBL] [Abstract][Full Text] [Related]
13. Glutathione contents in human and rodent tumor cells in various phases of the cell cycle. Lee FY; Siemann DW; Allalunis-Turner MJ; Keng PC Cancer Res; 1988 Jul; 48(13):3661-5. PubMed ID: 3378209 [TBL] [Abstract][Full Text] [Related]
14. Radiation survival parameters of antineoplastic drug-sensitive and -resistant human ovarian cancer cell lines and their modification by buthionine sulfoximine. Louie KG; Behrens BC; Kinsella TJ; Hamilton TC; Grotzinger KR; McKoy WM; Winker MA; Ozols RF Cancer Res; 1985 May; 45(5):2110-5. PubMed ID: 3986765 [TBL] [Abstract][Full Text] [Related]
15. Establishment of a melphalan-resistant rhabdomyosarcoma xenograft with cross-resistance to vincristine and enhanced sensitivity following buthionine sulfoximine-mediated glutathione depletion. Rosenberg MC; Colvin OM; Griffith OW; Bigner SH; Elion GB; Horton JK; Lilley E; Bigner DD; Friedman HS Cancer Res; 1989 Dec; 49(24 Pt 1):6917-22. PubMed ID: 2582434 [TBL] [Abstract][Full Text] [Related]
16. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells. Ali-Osman F; Antoun G; Wang H; Rajagopal S; Gagucas E Mol Pharmacol; 1996 Jun; 49(6):1012-20. PubMed ID: 8649339 [TBL] [Abstract][Full Text] [Related]
17. Effect of D,L-buthionine-S,R-sulfoximine on cytotoxicity and DNA cross-linking induced by bifunctional DNA-reactive cytostatic drugs in human melanoma cells. Hansson J; Edgren M; Ehrsson H; Ringborg U; Nilsson B Cancer Res; 1988 Jan; 48(1):19-26. PubMed ID: 3334994 [TBL] [Abstract][Full Text] [Related]
19. Changes in X-ray sensitivity and glutathione content of human colon tumor cells after exposure to the differentiation-inducing agent sodium butyrate. Leith JT; Hallows KT; Arundel CM; Bliven SF Radiat Res; 1988 Jun; 114(3):579-88. PubMed ID: 3375444 [TBL] [Abstract][Full Text] [Related]
20. Elevated DNA polymerase alpha, DNA polymerase beta, and DNA topoisomerase II in a melphalan-resistant rhabdomyosarcoma xenograft that is cross-resistant to nitrosoureas and topotecan. Friedman HS; Dolan ME; Kaufmann SH; Colvin OM; Griffith OW; Moschel RC; Schold SC; Bigner DD; Ali-Osman F Cancer Res; 1994 Jul; 54(13):3487-93. PubMed ID: 8012971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]